Azzurra Capital and The Club Dealers to acquire Domixtar Pharmaceutical from Alto Partners and Trilantic Europe.

Azzurra Capital and The Club Dealers, a private equity firms, agreed to acquire Domixtar Pharmaceutical, a pharmaceutical company, from Alto Partners, a private equity firm, and Trilantic Europe, a private equity firm. Financial terms were not disclosed. “We are particularly pleased to announce, together with TCD, the acquisition of a leading player in a strategic and highly resilient sector such as pharmaceutical CDMO. DMX stands out for its strong profitability and significant growth potential, both organically and through external consolidation opportunities. This transaction is fully aligned with our investment strategy, which focuses on sector-leading companies supported by management teams of proven excellence,” Stefano Marsaglia, Azzurra Capital, Founder and Chief Executive Officer.